Qiagen N.V. (QGEN)

NYSE: QGEN · Biological Products, (No Diagnostic Substances) · filing with the SEC since 1998

Grade6.3

◀ Past 7.5● Present 6.7▶ Future 4.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 20, 2026	Mar 31, 2025	Mar 11, 2024	Mar 13, 2023	Mar 14, 2022	Mar 5, 2021	Mar 2, 2020	Mar 6, 2019	Mar 6, 2018	Mar 6, 2017
Revenue	2,089,999	1,978,214	1,965,311	2,141,518	2,251,657	1,870,346	1,526,424	1,501,848	1,417,536	1,337,991
For lenders
Provision for credit losses	0	-5	5	5,574	2,155	1,325	·	·	·	·
Cost of revenue	790,504	1,010,864	731,623	756,955	800,837	637,631	521,162	500,888	494,975	493,338
Gross profit	1,299,495	967,350	1,233,688	1,384,563	1,450,820	1,232,715	1,005,262	1,000,960	922,561	844,653
Research and development	187,516	193,494	198,511	189,859	189,964	149,072	157,448	161,852	154,084	149,841^r
Sales and marketing	457,993	450,929	459,912	474,220	456,392	413,684	391,906	392,281	375,562	376,321^r
General and administrative	125,676	113,432	119,254	129,725	128,076	111,678	112,262	104,568	102,080	·
Total operating expenses	833,644	869,639	823,750	853,103	820,736	846,284	1,031,398	734,379	769,142	745,826
Operating income	465,851	97,711	409,938	531,460	630,084	386,431	-26,136	266,581	153,419	98,827
Interest expense	33,256	43,841	53,410	58,357	54,477	71,317	74,185	67,293	49,685	39,022
Interest and investment income	64,320	68,016	78,992	32,757	9,555	10,032	22,113	20,851	10,645	6,776
Share of profit of equity-method investments	4,401	5,720	4,163	3,758	11,987	5,018	2,083	2,592	3,164	2,821
Other income (expense), net	-6,650	-739	-5,711	6,741	40,671	114,326	432	5,598	-4	-9,673
Total non-operating income (expense)	24,414	23,436	19,871	-18,859	-4,251	53,041	-51,640	-40,844	-39,044	-41,919
Income before income taxes	490,265	121,147	429,809	512,601	625,833	439,472	-77,776	225,737	114,375	56,908
Income tax expense	65,385	37,556	88,506	89,390	113,234	80,284	-36,321	35,357	73,981	-23,395
Net income including non-controlling interests	·	·	·	·	·	·	-41,455	190,380	40,394	80,303
Net income to non-controlling interests	·	·	·	·	·	·	·	0	0	-101
Net income	424,880	83,591	341,303	423,211	512,599	359,188	-41,455	190,380	40,394	80,404
Earnings per share, basic	1.96	0.38	1.50	1.86	2.25	1.57	-0.18	0.84	0.18	0.34
Earnings per share, diluted	1.94	0.37	1.48	1.84	2.21	1.53	-0.18	0.82	0.17	0.34
Weighted average shares, basic	217,219	222,619	228,146	227,577	227,983	228,427	226,777	226,640	228,074	234,800
Weighted average shares, diluted	218,880	224,717	230,619	230,136	232,034	234,214	226,777	233,456	233,009	238,993

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet

Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLossesExpensed

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton QGEN · research, not advice